Regeneron Pharmaceuticals Stock Forecast
Regeneron Pharmaceuticals stock upgraded to Hold/Accumulate.
(Updated on Apr 24, 2024)
The Regeneron Pharmaceuticals stock price fell by -0.0860% on the last day (Wednesday, 24th Apr 2024) from $907.32 to $906.54. During the last trading day the stock fluctuated 1.25% from a day low at $904.41 to a day high of $915.70. The price has fallen in 6 of the last 10 days and is down by -3.17% for this period. Volume has increased on the last day by 29 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 370 thousand shares were bought and sold for approximately $335.16 million.
The stock lies in the lower of a falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $891.47 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -3.87% during the next 3 months and, with a 90% probability hold a price between $856.95 and $930.68 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
REGN Signals & Forecast
There are mixed signals in the stock today. The Regeneron Pharmaceuticals stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $943.27. On a fall, the stock will find some support from the short-term average at $900.02. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. A buy signal was issued from a pivot bottom point on Thursday, April 18, 2024, and so far it has risen 1.40%. Further rise is indicated until a new top pivot has been found.
Support, Risk & Stop-loss for Regeneron Pharmaceuticals stock
Regeneron Pharmaceuticals finds support from accumulated volume at $904.70 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $11.29 between high and low, or 1.25%. For the last week, the stock has had daily average volatility of 1.72%.
Our recommended stop-loss: $862.38 (-4.87%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 4 days ago.)
Trading Expectations (REGN) For The Upcoming Trading Day Of Thursday 25th
For the upcoming trading day on Thursday, 25th we expect Regeneron Pharmaceuticals to open at $908.88, and during the day (based on 14 day Average True Range), to move between $889.92 and $923.16, which gives a possible trading interval of +/-$16.62 (+/-1.83%) up or down from last closing price. If Regeneron Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 3.67% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $904.70 (0.20%) than the resistance at $945.18 (4.26%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Earnings coming up
Regeneron Pharmaceuticals will release earnings BMO on Thursday, May 02, 2024.The consensus among the analysts for the expected earnings (EPS) is $10.09. We will update the financials statements for Regeneron Pharmaceuticals, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 5.01% in the first trading day after earnings release.
Is Regeneron Pharmaceuticals stock A Buy?
Regeneron Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.
Current score: 0.272 Hold/Accumulate Upgraded
Predicted Opening Price for Regeneron Pharmaceuticals of Thursday, April 25, 2024
| Fair opening price April 25, 2024 | Current price |
|---|---|
| $908.88 ( 0.258%) | $906.54 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for REGN
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 920.17 | 1.50 % | |
| R2 | 915.86 | 1.03 % | ||
| R1 | 913.20 | 0.734 % | ||
| Current price: | 906.54 | |||
| Support | S1 | 904.57 | -0.217 % | |
| S2 | 901.91 | -0.511 % | ||
| S3 | 897.59 | -0.99 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 966.09 | 6.57 % | |
| R2 | 964.47 | 6.39 % | ||
| R1 | 945.18 | 4.26 % | ||
| Current price | 906.54 | |||
| Support | S1 | 904.70 | -0.203% | |
| S2 | 898.56 | -0.88% | ||
| S3 | 894.14 | -1.37% |
FAQ
Click here for our free guide on how to buy Regeneron Pharmaceuticals Stock.
